Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Recruiting

I'm Interested

Trial ID: NCT04579588

Age - 13-64 Gender - ALL Accepting Healthy Volunteers - yes

Purpose

The purpose of this study is to measure immunity to the flu vaccine over time in patients who have had COVID-19 and may have other medical conditions including obesity, type 2 diabetes, chronic fatigue, or long-term COVID-19 symptoms. Adults and children (age 13 to 64) who had been diagnosed with COVID-19 as well as controls without COVID-19 will be invited to participate in this study.

Official Title

Understanding Immunity to the Flu Vaccine in COVID-19 Patients

Stanford Investigator(s)

Sayantani Sindher

Clinical Professor, Medicine

Eligibility

Inclusion Criteria:

* Age 13 through 64 years
* Diagnosed with COVID-19 at least 2 months prior enrollment
* Patients with or without obesity, diabetes, chronic fatigue and/or long term COVID-19 symptoms
* Patients without COVID-19 diagnosis for controls

Exclusion Criteria:

* Received the influenza vaccine less than 4 months ago
* Pregnant or lactating
* Patients with special risks attendant to venipuncture
* Use of immunomodulatory medications
* Immunodeficiency or autoimmune disease

View More
View Less

Intervention(s):

biological: Flu shot

Recruiting

I'm Interested

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
SNP Center Inquiry
(650) 521-7237

©2025 Stanford Medicine